Net Profit Margin ratio Analysis of CytomX Therapeutics Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY NPM
Period Ending - Dec-23
Very Poor NPM
-10.75
Period Ending - Dec-22
Very Poor NPM
-186.82
Growth
94.25 %
Trailing Twelve Months NPM
Period Ending - Dec-23
Indecisive NPM
13.87
Most recent Quarter NPM
Period Ending - Mar-24
Excellent NPM
33.26
NPM Analysis of CytomX Therapeutics Inc
| NPM Ratio of CytomX Therapeutics Inc with value of 33.26 indicates that a company is able to control its costs effectively and offer goods or services at a much higher price than its costs in latest Quarter ending on Mar-24. |
| NPM Ratio of CTMX rose handsomely by 94.25 % this year. |
| NPM Ratio with value of -10.75 was highest in Year Dec-23 in last Five Years. |
| NPM Ratio with value of -186.82 was lowest in Year Dec-22 in last Five Years. |
| Latest NPM Ratio with value of -10.75 is Greater than Average NPM of -105.67 in last five years. |
| NPM of CytomX Therapeutics Inc is negative because of negative Net Profit in FY ended on Dec-23. |
Other NPM Related Info of CTMX that may interest you.
CytomX Therapeutics Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| CTMX | 1.37 | 1.38 | 0.725 % | Biotechnology |
Defination of Net Profit Margin
Net Margin is the company's Net Profit divided by the Total Revenue. This profitability metric indicates how much a net profit is generated for each rupee of revenue earned. In simple terms, it tells how much the company is generating profit for each rupee of revenue earned in percentage. It measures the company's profitability and management's capability to manage its expenses to generate profit. more ..
NPM Related Ratios
| ReturnOnEquity | EBITDAMargin |
Tsr Profitability Index
| Good Profitability | |
FY - Historical Net Profit Margin of CytomX Therapeutics Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| NPM | -10.75 | -186.82 | -120.17 | -32.77 | -177.84 | -142.19 | -60.17 |
| Change | 94.25 % | -55.45 % | -266.76 % | 81.58 % | -25.07 % | -136.29 % | 84.63 % |
FY Chart of Net Profit Margin of CytomX Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)